huperzine A nootropic
Selected indexed studies
- Huperzine A. (Drugs R D, 2004) [PMID:14725492]
- Over the Counter Supplements for Memory: A Review of Available Evidence. (CNS Drugs, 2023) [PMID:37603263]
- Huperzine A, a nootropic alkaloid, inhibits N-methyl-D-aspartate-induced current in rat dissociated hippocampal neurons. (Neuroscience, 2001) [PMID:11516831]
_Worker-drafted node — pending editorial review._
Connections
huperzine A nootropic protects against
Sources
- Huperzine A. (2004) pubmed
- Over the Counter Supplements for Memory: A Review of Available Evidence. (2023) pubmed
- Huperzine A, a nootropic alkaloid, inhibits N-methyl-D-aspartate-induced current in rat dissociated hippocampal neurons. (2001) pubmed
- Huperzine A Regulates the Physiological Homeostasis of Amyloid Precursor Protein Proteolysis and Tau Protein Conformation-A Computational and Experimental Investigation. (2024) pubmed
- Unauthorized ingredients in "nootropic" dietary supplements: A review of the history, pharmacology, prevalence, international regulations, and potential as doping agents. (2023) pubmed
- Huperzine A, a nootropic agent, inhibits fast transient potassium current in rat dissociated hippocampal neurons. (2002) pubmed
- Pharmacological treatments for vascular dementia: a systematic review and Bayesian network meta-analysis. (2024) pubmed
- Huperzine A, a novel promising acetylcholinesterase inhibitor. (1996) pubmed
- Tacrine-huperzine A hybrids (huprines): a new class of highly potent and selective acetylcholinesterase inhibitors of interest for the treatment of Alzheimer's disease. (2001) pubmed
- The effects of huperzine A and IDRA 21 on visual recognition memory in young macaques. (2011) pubmed